resveratrol has been researched along with cocaine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawahara, Y; Koga, Y; Kuroiwa, M; Nishi, A; Shuto, T; Sotogaku, N; Toyomasu, K | 1 |
| Miller, DK; Oelrichs, CE; Sage, AS; Simonyi, A; Sun, GY | 1 |
| Guan, X; Guan, Y; Hu, P; Jin, L; Zhu, C; Zhu, W | 1 |
| Li, Y; Liu, QS; Yu, L; Zeng, F; Zhao, L | 1 |
4 other study(ies) available for resveratrol and cocaine
| Article | Year |
|---|---|
Acute effects of resveratrol to enhance cocaine-induced dopamine neurotransmission in the striatum.
Topics: Animals; Central Nervous System Stimulants; Cocaine; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; In Vitro Techniques; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Neostriatum; Phosphorylation; Resveratrol; Stilbenes; Synaptic Transmission | 2013 |
Repeated resveratrol treatment attenuates methamphetamine-induced hyperactivity and [3H]dopamine overflow in rodents.
Topics: Animals; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Dopamine; Drug Antagonism; In Vitro Techniques; Male; Methamphetamine; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2013 |
Resveratrol fails to affect cocaine conditioned place preference behavior, but alleviates anxiety-like behaviors in cocaine withdrawn rats.
Topics: Animals; Anxiety; Behavior, Animal; Cocaine; Conditioning, Operant; Cytokines; Hippocampus; Male; Motor Activity; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Substance Withdrawal Syndrome | 2016 |
Resveratrol modulates cocaine-induced inhibitory synaptic plasticity in VTA dopamine neurons by inhibiting phosphodiesterases (PDEs).
Topics: Aging; Animals; Cocaine; Cocaine-Related Disorders; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopaminergic Neurons; Endocannabinoids; GABAergic Neurons; gamma-Aminobutyric Acid; Humans; Long-Term Synaptic Depression; Mice; Neuronal Plasticity; Neuroprotective Agents; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Resveratrol; Ventral Tegmental Area | 2017 |